Does neoadjuvant therapy contribute to increased risk in anastomotic leakage of esophageal cancer? A network meta‐analysis
Article in Journal of Evidence-Based Medicine (August 2024)
The most recent citing publications are shown below. View all 15 publications that cite this research output on Dimensions.
Neoadjuvant immunochemotherapy improves clinical outcomes of patients with esophageal cancer by mediating anti-tumor immunity of CD8+ T (Tc1) and CD16+ NK cells
Article in Frontiers in Immunology (July 2024)
Perioperative Outcomes and Survival after Neoadjuvant Immunochemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Article in Journal of Thoracic and Cardiovascular Surgery (June 2024)